- Home
- ROOT vs ARWR Comparison
ROOT vs ARWR Comparison
Compare ROOT & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROOT
- ARWR
- Stock Information
- Founded
- ROOT 2015
- ARWR 2003
- Country
- ROOT United States
- ARWR United States
- Employees
- ROOT N/A
- ARWR N/A
- Industry
- ROOT Property-Casualty Insurers
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- ROOT Finance
- ARWR Health Care
- Exchange
- ROOT Nasdaq
- ARWR Nasdaq
- Market Cap
- ROOT 2.3B
- ARWR 1.8B
- IPO Year
- ROOT 2020
- ARWR 1993
- Fundamental
- Price
- ROOT $137.80
- ARWR $16.40
- Analyst Decision
- ROOT Buy
- ARWR Buy
- Analyst Count
- ROOT 7
- ARWR 10
- Target Price
- ROOT $120.83
- ARWR $42.13
- AVG Volume (30 Days)
- ROOT 479.4K
- ARWR 1.9M
- Earning Date
- ROOT 05-07-2025
- ARWR 05-12-2025
- Dividend Yield
- ROOT N/A
- ARWR N/A
- EPS Growth
- ROOT N/A
- ARWR N/A
- EPS
- ROOT 3.16
- ARWR N/A
- Revenue
- ROOT $1,271,000,000.00
- ARWR $545,209,000.00
- Revenue This Year
- ROOT $22.14
- ARWR $4,380.43
- Revenue Next Year
- ROOT $10.44
- ARWR $66.56
- P/E Ratio
- ROOT $43.50
- ARWR N/A
- Revenue Growth
- ROOT 98.66
- ARWR 1436.97
- 52 Week Low
- ROOT $34.04
- ARWR $9.57
- 52 Week High
- ROOT $181.14
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- ROOT 52.19
- ARWR 61.50
- Support Level
- ROOT $123.65
- ARWR $14.92
- Resistance Level
- ROOT $133.55
- ARWR $17.19
- Average True Range (ATR)
- ROOT 7.84
- ARWR 0.94
- MACD
- ROOT -0.69
- ARWR 0.11
- Stochastic Oscillator
- ROOT 43.08
- ARWR 68.53
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.